Repare Therapeutics Inc. (RPTX)

Repare Therapeutics Statistics

Total Valuation

RPTX has a market cap or net worth of $53.14 million. The enterprise value is -$97.72 million.

Market Cap	53.14M
Enterprise Value	-97.72M

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025, after market close.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

RPTX has 42.51 million shares outstanding. The number of shares has increased by 0.76% in one year.

Current Share Class	42.51M
Shares Outstanding	42.51M
Shares Change (YoY)	+0.76%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.35%
Owned by Institutions (%)	31.05%
Float	22.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.99
Forward PS	5.82
PB Ratio	0.35
P/TBV Ratio	0.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.77, with a Debt / Equity ratio of 0.01.

Current Ratio	6.77
Quick Ratio	6.53
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -46.63% and return on invested capital (ROIC) is -31.25%.

Return on Equity (ROE)	-46.63%
Return on Assets (ROA)	-26.76%
Return on Invested Capital (ROIC)	-31.25%
Return on Capital Employed (ROCE)	-60.93%
Revenue Per Employee	$414,550
Profits Per Employee	-$656,504
Employee Count	129
Asset Turnover	0.25
Inventory Turnover	n/a

Taxes

In the past 12 months, RPTX has paid $1.44 million in taxes.

Income Tax	1.44M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.12% in the last 52 weeks. The beta is 0.91, so RPTX's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-62.12%
50-Day Moving Average	1.14
200-Day Moving Average	2.37
Relative Strength Index (RSI)	58.59
Average Volume (20 Days)	501,132

Short Selling Information

The latest short interest is 694,214, so 1.63% of the outstanding shares have been sold short.

Short Interest	694,214
Short Previous Month	795,854
Short % of Shares Out	1.63%
Short % of Float	3.07%
Short Ratio (days to cover)	1.86

Income Statement

In the last 12 months, RPTX had revenue of $53.48 million and -$84.69 million in losses. Loss per share was -$2.00.

Revenue	53.48M
Gross Profit	40.10M
Operating Income	-92.14M
Pretax Income	-83.68M
Net Income	-84.69M
EBITDA	-90.22M
EBIT	-92.14M
Loss Per Share	-$2.00

Balance Sheet

The company has $152.79 million in cash and $1.93 million in debt, giving a net cash position of $150.86 million or $3.55 per share.

Cash & Cash Equivalents	152.79M
Total Debt	1.93M
Net Cash	150.86M
Net Cash Per Share	$3.55
Equity (Book Value)	151.13M
Book Value Per Share	3.56
Working Capital	145.86M

Cash Flow

Operating Cash Flow	-76.45M
Capital Expenditures	n/a
Free Cash Flow	-76.45M
FCF Per Share	-$1.80

Margins

Gross margin is 74.98%, with operating and profit margins of -172.31% and -158.37%.

Gross Margin	74.98%
Operating Margin	-172.31%
Pretax Margin	-155.67%
Profit Margin	-158.37%
EBITDA Margin	-168.71%
EBIT Margin	-172.31%
FCF Margin	n/a

Dividends & Yields

RPTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.76%
Shareholder Yield	n/a
Earnings Yield	-159.37%
FCF Yield	-143.86%

Analyst Forecast

The average price target for RPTX is $4.50, which is 260.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	260.00%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RPTX has an Altman Z-Score of 0.3 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.3
Piotroski F-Score	4